Viral clearance studies prior to Phase I/II and inclusion in IND submissions for AAV product survey by Emma Howlett | Oct 27, 2021A survey to understand how member companies are performing viral clearance studies prior to Phase I/II and if members are including these studies within investigational new drug (IND) submission for adeno-associated virus (AAV) products.
